Cannamedical receives EUR15m equity investment from Orkila Capital
Cannamedical Pharma, an independent cannabis wholesaler in Germany and the European Union, has received a EUR15 million equity investment from the US- and Germany-based growth equity investment firm Orkila Capital. As a result of its investment, Orkila Capital has acquired a minority in Cannamedical. “I am very pleased that

